Veterinary Vaccines Market

Veterinary Vaccines Market: Faster Innovation and Better Relationship Management Key to Garner Higher Market Shares; Global Industry Analysis and Opportunity Assessment, 2016 – 2026

Introduction

Veterinary vaccines is the most lucrative product segment of focus for veterinary drug manufacturers, followed closely by parasiticides. Given the preventive nature of veterinary healthcare, the veterinary vaccine market is estimated to witness considerable revenue traction over the coming years. With increasing incidence of food-borne zoonotic diseases, global animal production has reduced by 15%–20% a year. Growing pet animal adoption trend due to increasingly secluded lifestyles, ageing global population and increasing per capita income levels are factors promoting demand for companion animal vaccines. Effective harmonization of product development, registration and approval guidelines could reduce time-to-market for veterinary vaccines. This could benefit all key stakeholders in the veterinary vaccine value chain – governments, drug makers, distributors, farm owners and pet animal owners.  

Market Value Forecast

In terms of value, the global veterinary vaccines market is anticipated to be valued at US$ 14,149 Mn by 2026, expanding at a moderate CAGR over the forecast period.    

Market Dynamics

Growth of the global veterinary vaccines market is mainly driven by improving food security along with rising humanization of pets and adoption. Increasing foodborne and zoonotic diseases, improving public health through controlling contagious diseases such as avian influenza and rising humanization of pets and adoption are some factors excepted to drive overall growth of the veterinary vaccines market. Companies are adopting various strategies to sustain in the market and create a distinct value proposition for diverse consumer segments in order to offer cost-effective treatment for animals. This is in turn expected to drive growth of the veterinary vaccines market in developing regions.  

The global veterinary vaccines market is expected to witness impressive growth over the forecast period. However, declining influence of veterinarians, gaps in epidemiological knowledge of certain virulent veterinary diseases and pitfalls in identifying and understanding antigen/immunogenic structures are factors expected to hamper revenue growth of the global veterinary vaccines market.    

Segmentation by Product

The global veterinary vaccines market is segmented on the basis of product type into attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines and recombinant vaccines. Among the product type segments, attenuated live vaccines segment accounts for highest market share and is expected to expand at the CAGR of 7.5% between 2015 and 2024.

Segmentation by Disease Application Type

The global veterinary vaccines market is segmented on the basis of disease application types into anaplasmosis, canine parvovirus, foot & mouth disease, newcastle disease, distemper disease, influenza, porcine reproductive & respiratory syndrome (PRRS) and others. Among the disease application type segments, foot & mouth disease segment currently accounts for highest market share.

Segmentation by Animal Type

The global veterinary vaccines market is segmented on the basis of animal type as companion animals, livestock animals and equine. Companion animals segment comprises three sub-segments namely – canine, avian and feline. Livestock segment comprises five sub-segments namely, aquatic, bovine, porcine, ovine and poultry. Among the animal type segments, livestock animals segment is expected to witness relatively impressive growth during the forecast period.

Segmentation by Distribution Channel

The global veterinary vaccines market is segmented on the basis of distribution channel veterinary clinics, veterinary hospitals, veterinary research institute and retail pharmacies. Among the distribution channel segments, veterinary clinics segment accounts for highest market share, and is expected to register a CAGR of 7.1% between 2015 and 2024.

Key Regions

By region, the global veterinary vaccines market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Middle East & Africa (MEA) and Japan.

Globally, in terms of revenue, North America has been estimated to account for largest share of 30.4% in 2016, followed by Western Europe. Meanwhile, revenue from the market in Asia Pacific excluding Japan (APEJ) is expected to expand at the highest CAGR of 9.1% over the forecast period.

veterinary-vaccines-market

Key Players

Key players in the global veterinary vaccines market include Merial, Zoetis, Elanco, Merck & Co. Inc., Boehringer Ingelheim GmbH )(BIVI), Bayer Pharma AG, Ceva, Verbac, Diamond Animal Healthcare (Heska) and Indian Immunological Ltd.

Majority of players operating in the veterinary vaccines market are focused on entering into collaborations and partnerships with local distributors and retailers in order to enhance their presence in markets in various countries across the globe. Moreover, collaborations and partnerships also enable these companies to increase visibility of their products in markets across the concerned regions. Besides, companies are focusing on improving their competitive capabilities to strengthen their market presence worldwide and expand customer base. 

This Future Market Insights report examines the ‘Global Veterinary Vaccines Market’ for the period 2016–2026. The primary objective of the report is to offer updates, trends, drivers, restraints, volume and value forecasts and opportunities for manufacturers operating in the global veterinary vaccines market.

Global demand for veterinary vaccines is increasing as a result of improving food security, Improving public health through controlling contagious diseases such as avian influenza, Increasing foodborne and zoonotic diseases and Rising humanization of pets and adoption. Markets in developed economies are witnessing increasing demand for veterinary vaccines due to rising adoption of tried and tested products and the trend is expected to boost the overall demand for veterinary vaccines such as e attenuated live vaccines during the forecast period. To understand and assess the opportunities in this market, the report is categorically split into four sections, namely market analysis by product type, disease application type, animal type, distribution type and region. The report analyses the global veterinary vaccines market in terms of market value (US$ Mn).

The report starts with an overview of the veterinary vaccines market and its usage in various applications globally. In the same section, FMI covers the veterinary vaccines market performance in terms of revenue. This section includes FMI’s analysis of key trends, drivers and restraints from the supply and demand side perspective.

The next section of the report analyses the market based on product type and presents the forecast in terms of value for the next 10 years. Product types covered in the report include:

  • Attenuated Live Vaccines Market
  • Conjugate Vaccines Market
  • Inactivated Vaccines Market
  • Subunit Vaccines Market
  • Toxoid Vaccines Market
  • DNA Vaccines Market
  • Recombinant Vaccines Market

The next section of the report analyses the market based on disease application type segments and presents the forecast in terms of value for the next ten years. The disease application type segments covered in the report include:

  • Anaplasmosis
  • Canine Parvovirus
  • Foot and Mouth Disease
  • New Castle Disease
  • Distemper Disease
  • Influenza
  • Porcine Reproductive & Respiratory Syndrome (PRRS)
  • Others

The next section of the report analyses the market based on animal type segments and presents the forecast in terms of value for the next ten years. The animal type segments covered in the report include:

  • Companion Animals
    • Canine
    • Avine
    • Feline
  • Livestock Animals
    • Aquatic
    • Bovine
    • Porcine
    • Ovine
    • Poultry
  • Equine

The next section of the report analyses the market based on distribution channel segments and presents the forecast in terms of value for the next ten years. The distribution channel segments covered in the report include:

  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Retail Pharmacies

Furthermore, the report analyses the market based on regions and presents the forecast in terms of value for the next ten years. Regions covered in the report include:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Middle East & Africa (MEA)
  • Japan

The forecast presented for the market assesses the total revenue generated in the veterinary vaccines market. When developing the forecast, the starting point involves sizing the current market, which forms the basis for the forecast of how the market is anticipated to take shape in the near future. Given the characteristics of market, we triangulated the outcome based on different analysis of the supply side, demand side and GDP growth rate. However, quantifying the market across aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalising them after the forecast has been completed.

In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global veterinary vaccines market.

As previously highlighted, the global veterinary vaccines market is split into various categories based on region, product type, animal type and application type and distribution channel type. All these segments or categories have been analyzed in terms of Basis Point Share (BPS) to understand the individual segments’ relative contribution to market growth. This detailed level of information is important for identification of various key trends in the global veterinary vaccines market.

Another key feature of this report is the analysis of the veterinary vaccines market by region and product type, animal type and application type and distribution channel type; and the market revenue forecast in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales perspective in the global veterinary vaccines market.

Table Of Content

1. Executive Summary

2. Research Methodology

3. Assumptions & Acronyms Used

4. Definition and Taxonomy

4.1.Market Definition

4.2.Taxonomy

5. Market Dynamics

5.1.Introduction

     5.1.1. Drivers

     5.1.2. Restraints

     5.1.3. Opportunity

     5.1.4. Trends

     5.1.5. Regulations

6. Overall Market Outlook

6.1.Section Summary

6.2.Global Veterinary Vaccines Market Forecast, 2015-2026

6.3.Introduction

     6.3.1. Y-o-Y Growth Projection

     6.3.2. Absolute $ Opportunity

7. Global Veterinary Vaccines Market Analysis, By Product Type

7.1. Introduction

     7.1.1. Global Veterinary Vaccines Market Overview

     7.1.2. Global Veterinary Vaccines Market Value Share, by Product Type

     7.1.3. Global Veterinary Vaccines Market Attractiveness by Product Type

     7.1.4. Y-o-Y Growth Comparison, By Product Type

7.2. Market Value Forecast, By Product Type

     7.2.1. Attenuated Live Vaccines

             7.2.1.1. Absolute $ Opportunity

             7.2.1.2. Market Value Forecast

     7.2.2. Inactivated Vaccines

             7.2.2.1. Absolute $ Opportunity

             7.2.2.2. Market Value Forecast 

     7.2.3. Subunit Vaccines

             7.2.3.1. Absolute $ Opportunity

             7.2.3.2. Market Value Forecast

     7.2.4. Toxoid Vaccines

             7.2.4.1. Absolute $ Opportunity

             7.2.4.2. Market Value Forecast

     7.2.5. DNA Vaccines

             7.2.5.1. Absolute $ Opportunity

             7.2.5.2. Market Value Forecast

     7.2.6. Recombinant Vaccines

             7.2.6.1. Absolute $ Opportunity

             7.2.6.2. Market Value Forecast

7.3. Global Veterinary Vaccines Market Trends, by Product Type

8. Global Veterinary Vaccines Market Analysis, By Diseases

8.1. Introduction

     8.1.1. Overview

     8.1.2. Global Veterinary Vaccines Market Value Share, by Diseases

     8.1.3. Global Veterinary Vaccines Market Attractiveness by Diseases

     8.1.4. Y-o-Y Growth Comparison, By Diseases

8.2. Market Value Forecast, By Diseases

     8.2.1. Anaplasmosis

             8.2.1.1. Absolute $ Opportunity

             8.2.1.2. Market Value Forecast

     8.2.2. Canine Parvovirus

             8.2.2.1. Absolute $ Opportunity

             8.2.2.2. Market Value Forecast

     8.2.3. Foot & Mouth Disease

             8.2.3.1. Absolute $ Opportunity

             8.2.3.2. Market Value Forecast

     8.2.4. Newcastle Disease

             8.2.4.1. Absolute $ Opportunity

             8.2.4.2. Market Value Forecast

     8.2.5. Distemper Disease

             8.2.5.1. Absolute $ Opportunity

             8.2.5.2. Market Value Forecast

     8.2.6. Influenza Disease

             8.2.6.1. Absolute $ Opportunity

             8.2.6.2. Market Value Forecast

     8.2.7. Porcine Reproductive & Respiratory Syndrome (PRRS) Disease 

             8.2.7.1. Absolute $ Opportunity

             8.2.7.2. Market Value Forecast

     8.2.8. Others Disease

             8.2.8.1. Absolute $ Opportunity

             8.2.8.2. Market Value Forecast 

8.3. Global Veterinary Vaccines Market Trends, by Diseases

9. Global Veterinary Vaccines Market Analysis, By Species Type

9.1. Introduction

     9.1.1. Overview

     9.1.2. Global Veterinary Vaccines Market Value Share, by Species Type

     9.1.3. Global Veterinary Vaccines Market Attractiveness By Species Type

     9.1.4. Y-o-Y Growth Comparison, By Species Type

9.2. Market Value Forecast, By Species Type

     9.2.1. Companion Animal

             9.2.1.1. Market Value Forecast

                       9.2.1.1.1. Canine

                       9.2.1.1.2. Avian

                       9.2.1.1.3. Feline

     9.2.2. Livestock Animals

             9.2.2.1. Market Value Forecast

                       9.2.2.1.1. Aquatic

                       9.2.2.1.2. Bovine

                       9.2.2.1.3. Porcine

                       9.2.2.1.4. Ovine/Caprine

                       9.2.2.1.5. Poultry

     9.2.3. Equine

             9.2.3.1. Absolute $ Opportunity

             9.2.3.2. Market Value Forecast 

9.3. Global Veterinary Vaccines Market Trends, by Species Type

10. Global Veterinary Vaccines Market Analysis, By Distribution Channel

10.1. Introduction

     10.1.1. Global Veterinary Vaccines Market Value Share, by Distribution Channel

     10.1.2. Global Veterinary Vaccines Market Attractiveness by Distribution Channel

     10.1.3. Y-o-Y Growth Comparison, By Distribution Channel

10.2. Market Value Forecast, By Distribution Channel

     10.2.1. Veterinary Clinic Segment

             10.2.1.1. Absolute $ Opportunity

             10.2.1.2. Market Value Forecast

     10.2.2. Veterinary Hospital Segment

             10.2.2.1. Absolute $ Opportunity

             10.2.2.2. Market Value Forecast

     10.2.3. Veterinary Research Institute

             10.2.3.1. Absolute $ Opportunity

             10.2.3.2. Market Value Forecast

     10.2.4. Retail Pharmacies

             10.2.4.1. Absolute $ Opportunity

             10.2.4.2. Market Value Forecast

10.3. Global Veterinary Vaccines Market Trends, by Distribution Channel

10.4. Global Veterinary Vaccines Market Trends, by Diseases

11.  Global Veterinary Vaccines Market Analysis, By Region

11.1. Introduction

     11.1.1. Global Veterinary Vaccines Market Value Share, by Region

     11.1.2. Global Veterinary Vaccines Market Attractiveness by Region

11.2. Market Value Forecast, By Region

     11.2.1. North America

     11.2.2. Latin America

     11.2.3. Western Europe

     11.2.4. Eastern Europe

     11.2.5. APEJ

     11.2.6. Japan

     11.2.7. MEA

12.  North America Veterinary Vaccines Market Analysis

12.1. Introduction

     12.1.1. North America Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

     12.1.2. North America Veterinary Vaccines Market Absolute $ Opportunity

     12.1.3. Market Value Forecast

             12.1.3.1. By Country

                       12.1.3.1.1.   U.S.

                       12.1.3.1.2.   Canada

             12.1.3.2. By Product Type

                       12.1.3.2.1. Attenuated Live Vaccines

                       12.1.3.2.2. Conjugate Vaccines

                       12.1.3.2.3. Inactivated Vaccines

                       12.1.3.2.4. Subunit Vaccines

                       12.1.3.2.5. Toxoid Vaccines

                       12.1.3.2.6. DNA Vaccines

                       12.1.3.2.7. Recombinant Vaccines

             12.1.3.3. By Diseases Type

                       12.1.3.3.1. Anaplasmosis

                       12.1.3.3.2. Canine Parvovirus

                       12.1.3.3.3. Foot & Mouth Disease

                       12.1.3.3.4. New Castle Disease

                       12.1.3.3.5. Distemper Disease

                       12.1.3.3.6. Influenza

                       12.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)

                       12.1.3.3.8. Others

             12.1.3.4. By Distribution Channel

                       12.1.3.4.1. Veterinary Clinics

                       12.1.3.4.2. Veterinary Hospitals

                       12.1.3.4.3. Veterinary Research Institutes

                       12.1.3.4.4. Retail Pharmacies & Others 

             12.1.3.5. By Species Type

                       12.1.3.5.1.   Companion Animals

                                      12.1.3.5.1.1. Canine

                                      12.1.3.5.1.2. Avian

                                      12.1.3.5.1.3. Feline

                       12.1.3.5.2. Livestock Animals

                                      12.1.3.5.2.1. Aquatic

                                      12.1.3.5.2.2. Bovine

                                      12.1.3.5.2.3. Porcine

                                      12.1.3.5.2.4. Ovine/Caprine

                                      12.1.3.5.2.5. Poultry

                       12.1.3.5.3. Equine

     12.1.4. North America Veterinary Vaccines Market Attractiveness

             12.1.4.1. By Country

             12.1.4.2. By Product Type

             12.1.4.3. By Diseases

             12.1.4.4. By Distribution Channel

             12.1.4.5. By Species Type

12.2. Drivers and Restraints Impact Analysis

13.   Latin America Veterinary Vaccines Market Analysis

13.1. Introduction

     13.1.1. Latin America Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

     13.1.2. Latin America Veterinary Vaccines Market Absolute $ Opportunity

     13.1.3. Market Value Forecast

             13.1.3.1.   By Country

                       13.1.3.1.1 Argentina

                       13.1.3.1.2. Brazil

                       13.1.3.1.3. Mexico

                       13.1.3.1.4. Rest of Latin America

             13.1.3.2. By Product Type

                       13.1.3.2.1. Attenuated Live Vaccines

                       13.1.3.2.2. Conjugate Vaccines

                       13.1.3.2.3. Inactivated Vaccines

                       13.1.3.2.4. Subunit Vaccines

                       13.1.3.2.5. Toxoid Vaccines

                       13.1.3.2.6. DNA Vaccines

                       13.1.3.2.7. Recombinant Vaccines

             13.1.3.3. By Diseases Type

                       13.1.3.3.1. Anaplasmosis

                       13.1.3.3.2. Canine Parvovirus

                       13.1.3.3.3. Foot & Mouth Disease

                       13.1.3.3.4. New Castle Disease

                       13.1.3.3.5. Distemper Disease

                       13.1.3.3.6. Influenza

                       13.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)

                       13.1.3.3.8. Others

             13.1.3.4. By Distribution Channel

                       13.1.3.4.1. Veterinary Clinics

                       13.1.3.4.2. Veterinary Hospitals

                       13.1.3.4.3. Veterinary Research Institutes

                       13.1.3.4.4. Retail Pharmacies & Others 

             13.1.3.5. By Species Type

                       13.1.3.5.1. Companion Animals

                                      13.1.3.5.1.1. Canine

                                      13.1.3.5.1.2. Avian

                                      13.1.3.5.1.3.  Feline

                       13.1.3.5.2. Livestock Animals

                                      13.1.3.5.2.1. Aquatic

                                      13.1.3.5.2.2. Bovine

                                      13.1.3.5.2.3. Porcine

                                      13.1.3.5.2.4. Ovine/Caprine

                                      13.1.3.5.2.5. Poultry

                       13.1.3.5.3.Equine

     13.1.4. Latin America Veterinary Vaccines Market Attractiveness

             13.1.4.1. By Country

             13.1.4.2. By Product Type

             13.1.4.3. By Diseases

             13.1.4.4. By Distribution Channel

             13.1.4.5. By Species Type

13.2. Drivers and Restraints Impact Analysis

14.  Western Europe Veterinary Vaccines Market Analysis

14.1. Introduction

     14.1.1. Western Europe Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

     14.1.2. Western Europe Veterinary Vaccines Market Absolute $ Opportunity

     14.1.3. Market Value Forecast

             14.1.3.1. By Country

                       14.1.3.1.1. Germany

                       14.1.3.1.2. Italy

                       14.1.3.1.3. France

                       14.1.3.1.4. UK

                       14.1.3.1.5. Spain

                       14.1.3.1.6. NORDIC Countries

                       14.1.3.1.7. Benelux

                       14.1.3.1.8. Rest of Western Europe

             14.1.3.2. By Product Type

                       14.1.3.2.1. Attenuated Live Vaccines

                       14.1.3.2.2. Conjugate Vaccines

                       14.1.3.2.3. Inactivated Vaccines

                       14.1.3.2.4. Subunit Vaccines

                       14.1.3.2.5. Toxoid Vaccines

                       14.1.3.2.6. DNA Vaccines

                       14.1.3.2.7. Recombinant Vaccines

             14.1.3.3.   By Diseases Type

                       14.1.3.3.1. Anaplasmosis

                       14.1.3.3.2. Canine Parvovirus

                       14.1.3.3.3. Foot & Mouth Disease

                       14.1.3.3.4. New Castle Disease

                       14.1.3.3.5. Distemper Disease

                       14.1.3.3.6. Influenza

                       14.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)

                       14.1.3.3.8. Others

             14.1.3.4.   By Distribution Channel

                       14.1.3.4.1. Veterinary Clinics

                       14.1.3.4.2. Veterinary Hospitals

                       14.1.3.4.3. Veterinary Research Institutes

                       14.1.3.4.4. Retail Pharmacies & Others 

             14.1.3.5. By Species Type

                       14.1.3.5.1. Companion Animals

                                      14.1.3.5.1.1. Canine

                                      14.1.3.5.1.2. Avian

                                      14.1.3.5.1.3. Feline

                       14.1.3.5.2. Livestock Animals

                                      14.1.3.5.2.1. Aquatic

                                      14.1.3.5.2.2. Bovine

                                      14.1.3.5.2.3. Porcine

                                      14.1.3.5.2.4. Ovine/Caprine

                                      14.1.3.5.2.5. Poultry

                       14.1.3.5.3. Equine

     14.1.4. Western Europe Veterinary Vaccines Market Attractiveness

             14.1.4.1. By Country

             14.1.4.2. By Product Type

             14.1.4.3. By Diseases

             14.1.4.4. By Distribution Channel

             14.1.4.5. By Species Type

14.2. Drivers and Restraints Impact Analysis 

15. Eastern Europe Veterinary Vaccines Market Analysis

15.1. Introduction

     15.1.1. Eastern Europe Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

     15.1.2. Eastern Europe Veterinary Vaccines Market Absolute $ Opportunity

     15.1.3. Market Value Forecast

             15.1.3.1. By Country

                       15.1.3.1.1. Russia

                       15.1.3.1.2. Poland

                       15.1.3.1.3. Rest of Eastern Europe

             15.1.3.2. By Product Type

                       15.1.3.2.1. Attenuated Live Vaccines

                       15.1.3.2.2. Conjugate Vaccines

                       15.1.3.2.3. Inactivated Vaccines

                       15.1.3.2.4. Subunit Vaccines

                       15.1.3.2.5. Toxoid Vaccines

                       15.1.3.2.6. DNA Vaccines

                       15.1.3.2.7. Recombinant Vaccines

             15.1.3.3. By Diseases Type

                       15.1.3.3.1. Anaplasmosis

                       15.1.3.3.2. Canine Parvovirus

                       15.1.3.3.3. Foot & Mouth Disease

                       15.1.3.3.4. New Castle Disease

                       15.1.3.3.5. Distemper Disease

                       15.1.3.3.6. Influenza

                       15.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)

                       15.1.3.3.8. Others

             15.1.3.4. By Distribution Channel

                       15.1.3.4.1. Veterinary Clinics

                       15.1.3.4.2. Veterinary Hospitals

                       15.1.3.4.3. Veterinary Research Institutes

                       15.1.3.4.4. Retail Pharmacies & Others 

             15.1.3.5. By Species Type

                       15.1.3.5.1. Companion Animals

                                      15.1.3.5.1.1. Canine

                                      15.1.3.5.1.2. Avian

                                      15.1.3.5.1.3. Feline

                       15.1.3.5.2. Livestock Animals

                                      15.1.3.5.2.1. Aquatic

                                      15.1.3.5.2.2. Bovine

                                      15.1.3.5.2.3. Porcine

                                      15.1.3.5.2.4. Ovine/Caprine

                                      15.1.3.5.2.5. Poultry

                       15.1.3.5.3. Equine

     15.1.4. Eastern Europe Veterinary Vaccines Market Attractiveness

             15.1.4.1. By Country

             15.1.4.2. By Product Type

             15.1.4.3. By Diseases

             15.1.4.4. By Distribution Channel

             15.1.4.5. By Species Type

15.2. Drivers and Restraints Impact Analysis

16.   APEJ Veterinary Vaccines Market Analysis

16.1. Introduction

     16.1.1. APEJ Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

     16.1.2. APEJ Veterinary Vaccines Market Absolute $ Opportunity

     16.1.3. Market Value Forecast

             16.1.3.1. By Country

                       16.1.3.1.1. Greater China

                       16.1.3.1.2. India

                       16.1.3.1.3. ASEAN

                       16.1.3.1.4. Australia and NZ

                       16.1.3.1.5. Rest of APEJ

             16.1.3.2. By Product Type

                       16.1.3.2.1. Attenuated Live Vaccines

                       16.1.3.2.2. Conjugate Vaccines

                       16.1.3.2.3. Inactivated Vaccines

                       16.1.3.2.4. Subunit Vaccines

                       16.1.3.2.5. Toxoid Vaccines

                       16.1.3.2.6. DNA Vaccines

                       16.1.3.2.7. Recombinant Vaccines

             16.1.3.3. By Diseases Type

                       16.1.3.3.1. Anaplasmosis

                       16.1.3.3.2. Canine Parvovirus

                       16.1.3.3.3. Foot & Mouth Disease

                       16.1.3.3.4. New Castle Disease

                       16.1.3.3.5. Distemper Disease

                       16.1.3.3.6. Influenza

                       16.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)

                       16.1.3.3.8. Others

             16.1.3.4. By Distribution Channel

                       16.1.3.4.1. Veterinary Clinics

                       16.1.3.4.2. Veterinary Hospitals

                       16.1.3.4.3. Veterinary Research Institutes

                       16.1.3.4.4. Retail Pharmacies & Others 

             16.1.3.5. By Species Type

                       16.1.3.5.1. Companion Animals

                                      16.1.3.5.1.1. Canine

                                      16.1.3.5.1.2. Avian

                                      16.1.3.5.1.3. Feline

                       16.1.3.5.2. Livestock Animals

                                      16.1.3.5.2.1. Aquatic

                                      16.1.3.5.2.2. Bovine

                                      16.1.3.5.2.3. Porcine

                                      16.1.3.5.2.4. Ovine/Caprine

                                      16.1.3.5.2.5. Poultry

                       16.1.3.5.3. Equine

     16.1.4. APEJ Veterinary Vaccines Market Attractiveness

             16.1.4.1. By Country

             16.1.4.2. By Product Type

             16.1.4.3. By Diseases

             16.1.4.4. By Distribution Channel

             16.1.4.5. By Species Type

16.2. Drivers and Restraints Impact Analysis

17. JAPAN Veterinary Vaccines Market Analysis

17.1. Introduction

     17.1.1. JAPAN Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

     17.1.2. JAPAN Veterinary Vaccines Market Absolute $ Opportunity

     17.1.3. Market Value Forecast

             17.1.3.1. By Product Type

                       17.1.3.1.1. Attenuated Live Vaccines

                       17.1.3.1.2. Conjugate Vaccines

                       17.1.3.1.3. Inactivated Vaccines

                       17.1.3.1.4. Subunit Vaccines

                       17.1.3.1.5. Toxoid Vaccines

                       17.1.3.1.6. DNA Vaccines

                       17.1.3.1.7. Recombinant Vaccines

             17.1.3.2.   By Diseases Type

                       17.1.3.2.1. Anaplasmosis

                       17.1.3.2.2. Canine Parvovirus

                       17.1.3.2.3. Foot & Mouth Disease

                       17.1.3.2.4. New Castle Disease

                       17.1.3.2.5. Distemper Disease

                       17.1.3.2.6. Influenza

                       17.1.3.2.7 Porcine Reproductive & Respiratory Syndrome (PRRS)

                       17.1.3.2.8. Others

             17.1.3.3. By Distribution Channel

                       17.1.3.3.1. Veterinary Clinics

                       17.1.3.3.2. Veterinary Hospitals

                       17.1.3.3.3. Veterinary Research Institutes

                       17.1.3.3.4. Retail Pharmacies & Others 

             17.1.3.4. By Species Type

                       17.1.3.4.1. Companion Animals

                                      17.1.3.4.1.1. Canine

                                      17.1.3.4.1.2. Avian

                                      17.1.3.4.1.3. Feline

                       17.1.3.4.2. Livestock Animals

                                      17.1.3.4.2.1. Aquatic

                                      17.1.3.4.2.2. Bovine

                                      17.1.3.4.2.3. Porcine

                                      17.1.3.4.2.4. Ovine/Caprine

                                      17.1.3.4.2.5. Poultry

                       17.1.3.4.3. Equine

     17.1.4. JAPAN Veterinary Vaccines Market Attractiveness

             17.1.4.1. By Country

             17.1.4.2. By Product Type

             17.1.4.3. By Diseases

             17.1.4.4. By Distribution Channel

             17.1.4.5. By Species Type

17.2. Drivers and Restraints Impact Analysis

18. MEA Veterinary Vaccines Market Analysis

18.1. Introduction

     18.1.1. MEA Veterinary Vaccines Market Value Forecast and Y-o-Y Growth

     18.1.2. MEA Veterinary Vaccines Market Absolute $ Opportunity

     18.1.3. Market Value Forecast

             18.1.3.1. By Country

                       18.1.3.1.1. GCC Countries

                       18.1.3.1.2. South Africa

                       18.1.3.1.3. Rest of MEA

             18.1.3.2. By Product Type

                       18.1.3.2.1. Attenuated Live Vaccines

                       18.1.3.2.2. Conjugate Vaccines

                       18.1.3.2.3. Inactivated Vaccines

                       18.1.3.2.4. Subunit Vaccines

                       18.1.3.2.5. Toxoid Vaccines

                       18.1.3.2.6. DNA Vaccines

                       18.1.3.2.7. Recombinant Vaccines

             18.1.3.3. By Diseases Type

                       18.1.3.3.1. Anaplasmosis

                       18.1.3.3.2. Canine Parvovirus

                       18.1.3.3.3. Foot & Mouth Disease

                       18.1.3.3.4. New Castle Disease

                       18.1.3.3.5. Distemper Disease

                       18.1.3.3.6. Influenza

                       18.1.3.3.7. Porcine Reproductive & Respiratory Syndrome (PRRS)

                       18.1.3.3.8. Others

             18.1.3.4. By Distribution Channel

                       18.1.3.4.1. Veterinary Clinics

                       18.1.3.4.2. Veterinary Hospitals

                       18.1.3.4.3. Veterinary Research Institutes

                       18.1.3.4.4. Retail Pharmacies & Others 

             18.1.3.5. By Species Type

                       18.1.3.5.1. Companion Animals

                                      18.1.3.5.1.1. Canine

                                      18.1.3.5.1.2. Avian

                                      18.1.3.5.1.3. Feline

                       18.1.3.5.2. Livestock Animals

                                      18.1.3.5.2.1. Aquatic

                                      18.1.3.5.2.2. Bovine

                                      18.1.3.5.2.3. Porcine

                                      18.1.3.5.2.4. Ovine/Caprine

                                      18.1.3.5.2.5. Poultry

                       18.1.3.5.3. Equine

     18.1.4. MEA Veterinary Vaccines Market Attractiveness

             18.1.4.1. By Country

             18.1.4.2. By Product Type

             18.1.4.3. By Diseases

             18.1.4.4. By Distribution Channel

             18.1.4.5. By Species Type

     18.1.5. Drivers and Restraints Impact Analysis

19. Competition Landscape

19.1. Competition Dashboard

19.2. Company Profiles

     19.2.1. Revenue

     19.2.2. Product Types/Brand Offerings

     19.2.3. Key developments

     19.2.4. SWOT Analysis

19.3. Company Highlights

     19.3.1. Merial

     19.3.2. Zoetis

     19.3.3. Elanco

     19.3.4. Merck & Co. Inc

     19.3.5. Borhinger Inghlem

     19.3.6. Bayer Phsrms Ag

     19.3.7. Ceva

     19.3.8. Verbs

List of Tables

Table 1: Global Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026

Table 2: Global Veterinary Vaccines Market Value (US$ Mn) by Diseases, 2015–2026

Table 3: Global Veterinary Vaccines Market Value (US$ Mn) By Distribution Channels, 2015–2026

Table 4: Global Veterinary Vaccines Market Value (US$ Mn) By Companion Animal Species Type, 2015–2026

Table 5: Global Veterinary Vaccines Market Value (US$ Mn) By Livestock Animal Species Type, 2015–2026

Table 6: North America Veterinary Vaccines Market Value (US$ Mn) by Country, 2015–2026

Table 7: North America Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026

Table 8: North America Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 9: North America Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 10: North America Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 11: North America Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 12: Latin America Veterinary Vaccines Market Value (US$ Mn) by Country, 2015–2026

Table 13: Latin America Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026

Table 14: Latin America Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 15: Latin America Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 16: Latin America Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 17: Latin America Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 18: Western Europe Veterinary Vaccines Market Value (US$ Mn) by Country, 2015–2026

Table 19: Western Europe Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026

Table 20: Western Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 21: Western Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 22: Western Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 23: Western Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 24: Eastern Europe Veterinary Vaccines Market Value (US$ Mn) by Country, 2015–2026

Table 25: Eastern Europe Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026

Table 26: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 27: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 28: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 29: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 30: APEJ Veterinary Vaccines Market Value (US$ Mn) by Country, 2015–2026

Table 31: APEJ Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026

Table 32: APEJ Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 33: APEJ Veterinary Vaccines Market Value (US$ Mn) By Distribution Channel, 2015–2026

Table 34: APEJ Veterinary Vaccines Market Value (US$ Mn) By Companion Animals Segment, 2015–2026

Table 35: APEJ Veterinary Vaccines Market Value (US$ Mn) By Livestock Animals Segment, 2015–2026

Table 36: MEA Veterinary Vaccines Market Value (US$ Mn) by Country, 2015–2026

Table 37: MEA Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026

Table 38: MEA Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 39: MEA Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 40: MEA Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 41: MEA Veterinary Vaccines Market Value (US$ Mn), 2015–2026

Table 42: Japan Veterinary Vaccines Market Value, By Product Type (US$ Mn), 2015–2026

Table 43: Japan Veterinary Vaccines Market Value (US$ Mn) By Diseases, 2015–2026

Table 44: Japan Veterinary Vaccines Market Value (US$ Mn) By Distribution Channels, 2015–2026

Table 45: Japan Veterinary Vaccines Market Value (US$ Mn) By Companion Animal Species Type, 2015–2026

Table 46: Japan Veterinary Vaccines Market Value (US$ Mn) By Livestock Animal Species Type, 2015–2026

List of Figures

Figure 1: Global Veterinary Vaccines Market Value (US$ Mn) & Growth Forecast, 2015–2026

Figure 2: Global Veterinary Vaccines Market Absolute $ Opportunity, 2015–2026

Figure 3: Global Veterinary Vaccines Market Value Share (%), By Product Type, 2016 & 2026

Figure 4: Global Veterinary Vaccines Market Attractiveness, By Product Type, 2015–2026

Figure 5: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Attenuated Live Vaccines Segment, 2015–2026

Figure 6: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Conjugate Vaccines Segment, 2015–2026

Figure 7: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Inactivated Vaccines Product Type, 2015–2026

Figure 8: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Subunit Vaccines Product Type, 2015–2026

Figure 9: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Toxoid Vaccines, 2015–2026

Figure 11: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Recombinant Vaccines, 2015–2026

Figure 12: Global Veterinary Vaccines Market Absolute $ Opportunity, by Attenuated Live Vaccines Segment, 2015 – 2026 (US$ Mn)

Figure 13: Global Veterinary Vaccines Market Absolute $ Opportunity, by Conjugate Vaccines, 2015 – 2026 (US$ Mn)

Figure 14: Global Veterinary Vaccines Market Absolute $ Opportunity, by Inactivated Vaccines Segment, 2015 – 2026 (US$ Mn)

Figure 15: Global Veterinary Vaccines Market Absolute $ Opportunity, by Subunit Vaccines Segment, 2015 – 2026 (US$ Mn)

Figure 16: Global Veterinary Vaccines Market Absolute $ Opportunity, by Toxoid Vaccines Segment, 2015 – 2026 (US$ Mn)

Figure 17: Global Veterinary Vaccines Market Absolute $ Opportunity, DNA Vaccines Segment, 2015 – 2026 (US$ Mn)

Figure 18: Global Veterinary Vaccines Market Absolute $ Opportunity, by Recombinant Vaccines Segment, 2015 – 2026 (US$ Mn)

Figure 19: Global Veterinary Vaccines Market Value Share (%), By Disease Type, 2016 & 2026

Figure 20: Global Veterinary Vaccines Market Attractiveness, By Disease Type, 2015–2026

Figure 21: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Anaplasmosis Disease Type, 2015–2026

Figure 23: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Foot & Mouth Disease Type, 2015–2026

Figure 24: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, Newcastle Disease Type, 2015–2026

Figure 26: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Influenza, Disease Type, 2015–2026

Figure 27: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Porcine Reproductive & Respiratory Syndrome (PRRS) Disease Type, 2015–2026

Figure 28: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Others Disease Type, 2015–2026

Figure 29: Global Veterinary Vaccines Market Absolute $ Opportunity, by Anaplasmosis Segment, 2015– 2026 (US$ Mn)

Figure 30: Global Veterinary Vaccines Market Absolute $ Opportunity, by Canine Parvovirus Segment, 2015 – 2026 (US$ Mn)

Figure 31: Global Veterinary Vaccines Market Absolute $ Opportunity, by Foot & Mouth Disease diseases Segment, 2015 – 2026 (US$ Mn)

Figure 32: Global Veterinary Vaccines Market Absolute $ Opportunity, by Newcastle Disease Segment, 2015 – 2026 (US$ Mn)

Figure 33: Global Veterinary Vaccines Market Absolute $ Opportunity, by Distemper Disease Segment, 2015 – 2026 (US$ Mn)

Figure 34: Global Veterinary Vaccines Market Absolute $ Opportunity, by Influenza Disease Segment, 2015 – 2026 (US$ Mn)

Figure 35: Global Veterinary Vaccines Market Absolute $ Opportunity, by Porcine Reproductive & Respiratory Syndrome (PRRS) Disease Segment, 2015 – 2026 (US$ Mn)

Figure 36: Global Veterinary Vaccines Market Absolute $ Opportunity, by Others Disease Segment, 2015 – 2026 (US$ Mn)

Figure 37: Global Veterinary Vaccines Market Value Share (%), By Distribution Channels, 2016 & 2026

Figure 38: Global Veterinary Vaccines Market Attractiveness, By Distribution Channels, 2015–2026

Figure 39: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, by Veterinary Clinic Segment, 2015 – 2026 (US$ Mn)

Figure 41: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, by Veterinary Research Institutes Segment, 2015 – 2026 (US$ Mn)

Figure 42: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, by Retail Pharmaciess Segment, 2015 – 2026 (US$ Mn)

Figure 43: Global Veterinary Vaccines Market Absolute $ Opportunity, by Veterinary Clinic Segment, 2015 – 2026 (US$ Mn)

Figure 44: Global Veterinary Vaccines Market Absolute $ Opportunity, by Veterinary Hospitals Segment, 2015 – 2026 (US$ Mn)

Figure 45: Global Veterinary Vaccines Market Absolute $ Opportunity, by Veterinary Research Institutes Segment, 2015 – 2026 (US$ Mn)

Figure 46: Global Veterinary Vaccines Market Absolute $ Opportunity, by Veterinary Retail Pharmaciess Segment, 2015 – 2026 (US$ Mn)

Figure 47: Global Veterinary Vaccines Market Value Share (%), By Species Type, 2016 & 2026

Figure 48: Global Veterinary Vaccines Market Attractiveness, By Species Type, 2015–2026

Figure 49: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Companion Animal Species Type, 2015–2026

Figure 51: Global Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, By Equine Species Type, 2015–2026

Figure 52: Global Veterinary Vaccines Market Absolute $ Opportunity, by Companion Animal Species Type, 2015 – 2026 (US$ Mn)

Figure 53: Global Veterinary Vaccines Market Absolute $ Opportunity, by Livestock Animal Species Type, 2015 – 2026 (US$ Mn)

Figure 54: Global Veterinary Vaccines Market Absolute $ Opportunity, by Equine Species Type, 2015 – 2026 (US$ Mn)

Figure 55: Global Veterinary Vaccines Market Value Share (%), Region, 2016 & 2026

Figure 56: Global Veterinary Vaccines Market Attractiveness, By Region, 2015–2026

Figure 57: North America Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, 2015–2026

Figure 58: North America Veterinary Vaccines Market Share, By Country, 2015–2026

Figure 59: North America Veterinary Vaccines Market Value (US$ Mn), By Country, 2015–2026

Figure 60: North America Veterinary Vaccines Market Growth, By Country, 2015–2026

Figure 61: North America Veterinary Vaccines Market Share, By Product Type, 2016 & 2026

Figure 62: North America Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026

Figure 63: North America Veterinary Vaccines Market Growth, By Product Type, 2015–2026

Figure 64: North America Veterinary Vaccines Market Share, By Diseases, 2015–2026

Figure 65: North America Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026

Figure 66: North America Veterinary Vaccines Market Growth, By Diseases, 2015–2026

Figure 67: North America Veterinary Vaccines Market Share, By Distribution Channel, 2015–2026

Figure 68: North America Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026

Figure 69: North America Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026

Figure 70: North America Veterinary Vaccines Market Share, By Species, 2015–2026

Figure 71: North America Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026

Figure 72: North America Veterinary Vaccines Market Growth, By Species, 2015–2026

Figure 73: Latin America Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, 2015–2026

Figure 74: Latin America Veterinary Vaccines Market Share, By Country, 2015–2026

Figure 75: Latin America Veterinary Vaccines Market Value (US$ Mn), By Country, 2015–2026

Figure 76: Latin America Veterinary Vaccines Market Growth, By Country, 2015–2026

Figure 77: Latin America Veterinary Vaccines Market Share, By Product Type, 2015–2026

Figure 78: Latin America Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026

Figure 79: Latin America Veterinary Vaccines Market Growth, By Product Type, 2015–2026

Figure 80: Latin America Veterinary Vaccines Market Share, By Diseases, 2015–2026

Figure 81: Latin America Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026

Figure 82: Latin America Veterinary Vaccines Market Growth, By Diseases, 2015–2026

Figure 83: Latin America Veterinary Vaccines Market Share, By Distribution Channel, 2015–2026

Figure 84: Latin America Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026

Figure 85: Latin America Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026

Figure 86: Latin America Veterinary Vaccines Market Share, By Species, 2015–2026

Figure 87: Latin America Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026

Figure 88: Latin America Veterinary Vaccines Market Growth, By Species, 2015–2026

Figure 89: Western Europe Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, 2015–2026

Figure 90: Western Europe Veterinary Vaccines Market Share, By Country, 2015–2026

Figure 91: Western Europe Veterinary Vaccines Market Value (US$ Mn), By Country, 2015–2026

Figure 92: Western Europe Veterinary Vaccines Market Growth, By Country, 2015–2026

Figure 93: Western Europe Veterinary Vaccines Market Share, By Product Type, 2015–2026

Figure 94: Western Europe Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026

Figure 95: Western Europe Veterinary Vaccines Market Growth, By Product Type, 2015–2026

Figure 96: Western Europe Veterinary Vaccines Market Share, By Diseases, 2015–2026

Figure 97: Western Europe Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026

Figure 98: Western Europe Veterinary Vaccines Market Growth, By Diseases, 2015–2026

Figure 99: Western Europe Veterinary Vaccines Market Share, By Distribution Channel, 2015–2026

Figure 100: Western Europe Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026

Figure 101: Western Europe Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026

Figure 102: Western Europe Veterinary Vaccines Market Share, By Species, 2015–2026

Figure 103: Western Europe Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026

Figure 104: Western Europe Veterinary Vaccines Market Growth, By Species, 2015–2026

Figure 105: Eastern Europe Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, 2015–2026

Figure 106: Eastern Europe Veterinary Vaccines Market Share, By Country, 2015–2026

Figure 107: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), By Country, 2015–2026

Figure 108: Eastern Europe Veterinary Vaccines Market Growth, By Country, 2015–2026

Figure 109: Eastern Europe Veterinary Vaccines Market Share, By Product Type, 2015–2026

Figure 110: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026

Figure 111: Eastern Europe Veterinary Vaccines Market Growth, By Product Type, 2015–2026

Figure 112: Eastern Europe Veterinary Vaccines Market Share, By Diseases, 2015–2026

Figure 113: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026

Figure 114: Eastern Europe Veterinary Vaccines Market Growth, By Diseases, 2015–2026

Figure 115: Eastern Europe Veterinary Vaccines Market Share, By Distribution Channel, 2015–2026

Figure 116: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026

Figure 117: Eastern Europe Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026

Figure 118: Eastern Europe Veterinary Vaccines Market Share, By Species, 2015–2026

Figure 119: Eastern Europe Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026

Figure 120: Eastern Europe Veterinary Vaccines Market Growth, By Species, 2015–2026

Figure 121: APEJ Veterinary Vaccines Market Value (US$ Mn) & Y-o-Y Growth (%) Forecast, 2015–2026

Figure 122: APEJ Veterinary Vaccines Market Share, By Country, 2016 & 2026

Figure 123: APEJ Veterinary Vaccines Market Value (US$ Mn), By Country, 2015–2026

Figure 124: APEJ Veterinary Vaccines Market Growth, By Country, 2015–2026

Figure 125: APEJ Veterinary Vaccines Market Share, By Product Type, 2016 & 2026

Figure 126: APEJ Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026

Figure 127: APEJ Veterinary Vaccines Market Growth, By Product Type, 2015–2026

Figure 128: APEJ Veterinary Vaccines Market Share, By Diseases, 2016 & 2026

Figure 129: APEJ Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026

Figure 130: APEJ Veterinary Vaccines Market Growth, By Diseases, 2015–2026

Figure 131: APEJ Veterinary Vaccines Market Share, By Distribution Channel, 2016 & 2026

Figure 132: APEJ Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026

Figure 133: APEJ Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026

Figure 134: APEJ Veterinary Vaccines Market Share, By Species, 2015–2026

Figure 135: APEJ Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026

Figure 136: APEJ Veterinary Vaccines Market Growth, By Species, 2015–2026

Figure 137: MEA Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, 2015–2026

Figure 138: MEA Veterinary Vaccines Market Share, By Country, 2015–2026

Figure 139: MEA Veterinary Vaccines Market Value (US$ Mn), By Country, 2015–2026

Figure 140: MEA Veterinary Vaccines Market Growth, By Country, 2015–2026

Figure 141: MEA Veterinary Vaccines Market Share, By Product Type, 2015–2026

Figure 142: MEA Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026

Figure 143: MEA Veterinary Vaccines Market Growth, By Product Type, 2015–2026

Figure 144: MEA Veterinary Vaccines Market Share, By Diseases, 2015–2026

Figure 145: MEA Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026

Figure 146: MEA Veterinary Vaccines Market Growth, By Diseases, 2015–2026

Figure 147: MEA Veterinary Vaccines Market Share, By Distribution Channel, 2015–2026

Figure 148: MEA Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026

Figure 149: MEA Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026

Figure 150: MEA Veterinary Vaccines Market Share, By Species, 2015–2026

Figure 151: MEA Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026

Figure 152: MEA Veterinary Vaccines Market Growth, By Species, 2015–2026

Figure 153: Japan Veterinary Vaccines Market Value (US$ Mn) & Growth (%) Forecast, 2015–2026

Figure 154: Japan Veterinary Vaccines Market Share, By Product Type, 2016 & 2026

Figure 155: Japan Veterinary Vaccines Market Value (US$ Mn), By Product Type, 2015–2026

Figure 156: Japan Veterinary Vaccines Market Growth, By Product Type, 2015–2026

Figure 157: Japan Veterinary Vaccines Market Share, By Diseases, 2016 & 2026

Figure 158: Japan Veterinary Vaccines Market Value (US$ Mn), By Diseases, 2015–2026

Figure 159: Japan Veterinary Vaccines Market Growth, By Diseases, 2015–2026

Figure 160: Japan Veterinary Vaccines Market Share, By Distribution Channel, 2016 & 2026

Figure 161: Japan Veterinary Vaccines Market Value (US$ Mn), By Distribution Channel, 2015–2026

Figure 162: Japan Veterinary Vaccines Market Growth, By Distribution Channel, 2015–2026

Figure 165: Japan Veterinary Vaccines Market Share, By Species, 2016 & 2026

Figure 166: Japan Veterinary Vaccines Market Value (US$ Mn), By Species, 2015–2026

Figure 167: Japan Veterinary Vaccines Market Growth, By Species, 2015–2026